img

Global Moclobemide Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Moclobemide Market Research Report 2024

Moclobemide is a monoamine oxidase (MAO) inhibitor used to treat certain types of mental depression. It works by blocking the action of a chemical substance known as monoamine oxidase (MAO) in the nervous system.
According to Mr Accuracy reports’s new survey, global Moclobemide market is projected to reach US$ 165.1 million in 2029, increasing from US$ 125 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Moclobemide market research.
Moclobemide is an antidepressant that has been on the market, but its market presence is relatively small. While approved for use in some countries, its market share remains modest compared to other antidepressant drugs. However, with the increasing prevalence of mental health issues such as depression and anxiety, and the demand for safer and more effective treatment options, there might be potential for future development in the Moclobemide market. Key factors for future growth include continued clinical research, effective marketing efforts, and ensuring the product's safety and efficacy to meet the needs of patients and physicians.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Moclobemide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Viatris
Apotex
Arrow Pharmaceuticals
Sandoz
Lunan Pharmaceutical
Segment by Type
150mg
300mg

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Moclobemide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Moclobemide Market Overview
1.1 Product Overview and Scope of Moclobemide
1.2 Moclobemide Segment by Type
1.2.1 Global Moclobemide Market Value Comparison by Type (2024-2034)
1.2.2 150mg
1.2.3 300mg
1.3 Moclobemide Segment by Application
1.3.1 Global Moclobemide Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Moclobemide Market Size Estimates and Forecasts
1.4.1 Global Moclobemide Revenue 2018-2029
1.4.2 Global Moclobemide Sales 2018-2029
1.4.3 Global Moclobemide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Moclobemide Market Competition by Manufacturers
2.1 Global Moclobemide Sales Market Share by Manufacturers (2018-2024)
2.2 Global Moclobemide Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Moclobemide Average Price by Manufacturers (2018-2024)
2.4 Global Moclobemide Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Moclobemide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Moclobemide, Product Type & Application
2.7 Moclobemide Market Competitive Situation and Trends
2.7.1 Moclobemide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Moclobemide Players Market Share by Revenue
2.7.3 Global Moclobemide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Moclobemide Retrospective Market Scenario by Region
3.1 Global Moclobemide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Moclobemide Global Moclobemide Sales by Region: 2018-2029
3.2.1 Global Moclobemide Sales by Region: 2018-2024
3.2.2 Global Moclobemide Sales by Region: 2024-2029
3.3 Global Moclobemide Global Moclobemide Revenue by Region: 2018-2029
3.3.1 Global Moclobemide Revenue by Region: 2018-2024
3.3.2 Global Moclobemide Revenue by Region: 2024-2029
3.4 North America Moclobemide Market Facts & Figures by Country
3.4.1 North America Moclobemide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Moclobemide Sales by Country (2018-2029)
3.4.3 North America Moclobemide Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Moclobemide Market Facts & Figures by Country
3.5.1 Europe Moclobemide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Moclobemide Sales by Country (2018-2029)
3.5.3 Europe Moclobemide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Moclobemide Market Facts & Figures by Country
3.6.1 Asia Pacific Moclobemide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Moclobemide Sales by Country (2018-2029)
3.6.3 Asia Pacific Moclobemide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Moclobemide Market Facts & Figures by Country
3.7.1 Latin America Moclobemide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Moclobemide Sales by Country (2018-2029)
3.7.3 Latin America Moclobemide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Moclobemide Market Facts & Figures by Country
3.8.1 Middle East and Africa Moclobemide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Moclobemide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Moclobemide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Moclobemide Sales by Type (2018-2029)
4.1.1 Global Moclobemide Sales by Type (2018-2024)
4.1.2 Global Moclobemide Sales by Type (2024-2029)
4.1.3 Global Moclobemide Sales Market Share by Type (2018-2029)
4.2 Global Moclobemide Revenue by Type (2018-2029)
4.2.1 Global Moclobemide Revenue by Type (2018-2024)
4.2.2 Global Moclobemide Revenue by Type (2024-2029)
4.2.3 Global Moclobemide Revenue Market Share by Type (2018-2029)
4.3 Global Moclobemide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Moclobemide Sales by Application (2018-2029)
5.1.1 Global Moclobemide Sales by Application (2018-2024)
5.1.2 Global Moclobemide Sales by Application (2024-2029)
5.1.3 Global Moclobemide Sales Market Share by Application (2018-2029)
5.2 Global Moclobemide Revenue by Application (2018-2029)
5.2.1 Global Moclobemide Revenue by Application (2018-2024)
5.2.2 Global Moclobemide Revenue by Application (2024-2029)
5.2.3 Global Moclobemide Revenue Market Share by Application (2018-2029)
5.3 Global Moclobemide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Roche Moclobemide Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Viatris Moclobemide Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Apotex Moclobemide Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Arrow Pharmaceuticals
6.4.1 Arrow Pharmaceuticals Corporation Information
6.4.2 Arrow Pharmaceuticals Description and Business Overview
6.4.3 Arrow Pharmaceuticals Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Arrow Pharmaceuticals Moclobemide Product Portfolio
6.4.5 Arrow Pharmaceuticals Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Sandoz Moclobemide Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Lunan Pharmaceutical
6.6.1 Lunan Pharmaceutical Corporation Information
6.6.2 Lunan Pharmaceutical Description and Business Overview
6.6.3 Lunan Pharmaceutical Moclobemide Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Lunan Pharmaceutical Moclobemide Product Portfolio
6.6.5 Lunan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Moclobemide Industry Chain Analysis
7.2 Moclobemide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Moclobemide Production Mode & Process
7.4 Moclobemide Sales and Marketing
7.4.1 Moclobemide Sales Channels
7.4.2 Moclobemide Distributors
7.5 Moclobemide Customers
8 Moclobemide Market Dynamics
8.1 Moclobemide Industry Trends
8.2 Moclobemide Market Drivers
8.3 Moclobemide Market Challenges
8.4 Moclobemide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Moclobemide Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Moclobemide Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Moclobemide Market Competitive Situation by Manufacturers in 2022
Table 4. Global Moclobemide Sales (Ton) of Key Manufacturers (2018-2024)
Table 5. Global Moclobemide Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Moclobemide Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Moclobemide Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Moclobemide Average Price (US$/Kg) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Moclobemide, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Moclobemide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Moclobemide, Product Type & Application
Table 12. Global Key Manufacturers of Moclobemide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Moclobemide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Moclobemide as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Moclobemide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Moclobemide Sales by Region (2018-2024) & (Ton)
Table 18. Global Moclobemide Sales Market Share by Region (2018-2024)
Table 19. Global Moclobemide Sales by Region (2024-2029) & (Ton)
Table 20. Global Moclobemide Sales Market Share by Region (2024-2029)
Table 21. Global Moclobemide Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Moclobemide Revenue Market Share by Region (2018-2024)
Table 23. Global Moclobemide Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Moclobemide Revenue Market Share by Region (2024-2029)
Table 25. North America Moclobemide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Moclobemide Sales by Country (2018-2024) & (Ton)
Table 27. North America Moclobemide Sales by Country (2024-2029) & (Ton)
Table 28. North America Moclobemide Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Moclobemide Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Moclobemide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Moclobemide Sales by Country (2018-2024) & (Ton)
Table 32. Europe Moclobemide Sales by Country (2024-2029) & (Ton)
Table 33. Europe Moclobemide Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Moclobemide Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Moclobemide Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Moclobemide Sales by Region (2018-2024) & (Ton)
Table 37. Asia Pacific Moclobemide Sales by Region (2024-2029) & (Ton)
Table 38. Asia Pacific Moclobemide Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Moclobemide Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Moclobemide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Moclobemide Sales by Country (2018-2024) & (Ton)
Table 42. Latin America Moclobemide Sales by Country (2024-2029) & (Ton)
Table 43. Latin America Moclobemide Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Moclobemide Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Moclobemide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Moclobemide Sales by Country (2018-2024) & (Ton)
Table 47. Middle East & Africa Moclobemide Sales by Country (2024-2029) & (Ton)
Table 48. Middle East & Africa Moclobemide Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Moclobemide Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Moclobemide Sales (Ton) by Type (2018-2024)
Table 51. Global Moclobemide Sales (Ton) by Type (2024-2029)
Table 52. Global Moclobemide Sales Market Share by Type (2018-2024)
Table 53. Global Moclobemide Sales Market Share by Type (2024-2029)
Table 54. Global Moclobemide Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Moclobemide Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Moclobemide Revenue Market Share by Type (2018-2024)
Table 57. Global Moclobemide Revenue Market Share by Type (2024-2029)
Table 58. Global Moclobemide Price (US$/Kg) by Type (2018-2024)
Table 59. Global Moclobemide Price (US$/Kg) by Type (2024-2029)
Table 60. Global Moclobemide Sales (Ton) by Application (2018-2024)
Table 61. Global Moclobemide Sales (Ton) by Application (2024-2029)
Table 62. Global Moclobemide Sales Market Share by Application (2018-2024)
Table 63. Global Moclobemide Sales Market Share by Application (2024-2029)
Table 64. Global Moclobemide Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Moclobemide Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Moclobemide Revenue Market Share by Application (2018-2024)
Table 67. Global Moclobemide Revenue Market Share by Application (2024-2029)
Table 68. Global Moclobemide Price (US$/Kg) by Application (2018-2024)
Table 69. Global Moclobemide Price (US$/Kg) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 73. Roche Moclobemide Product
Table 74. Roche Recent Developments/Updates
Table 75. Viatris Corporation Information
Table 76. Viatris Description and Business Overview
Table 77. Viatris Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 78. Viatris Moclobemide Product
Table 79. Viatris Recent Developments/Updates
Table 80. Apotex Corporation Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 83. Apotex Moclobemide Product
Table 84. Apotex Recent Developments/Updates
Table 85. Arrow Pharmaceuticals Corporation Information
Table 86. Arrow Pharmaceuticals Description and Business Overview
Table 87. Arrow Pharmaceuticals Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 88. Arrow Pharmaceuticals Moclobemide Product
Table 89. Arrow Pharmaceuticals Recent Developments/Updates
Table 90. Sandoz Corporation Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 93. Sandoz Moclobemide Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Lunan Pharmaceutical Corporation Information
Table 96. Lunan Pharmaceutical Description and Business Overview
Table 97. Lunan Pharmaceutical Moclobemide Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 98. Lunan Pharmaceutical Moclobemide Product
Table 99. Lunan Pharmaceutical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Moclobemide Distributors List
Table 103. Moclobemide Customers List
Table 104. Moclobemide Market Trends
Table 105. Moclobemide Market Drivers
Table 106. Moclobemide Market Challenges
Table 107. Moclobemide Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Moclobemide
Figure 2. Global Moclobemide Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Moclobemide Market Share by Type in 2022 & 2029
Figure 4. 150mg Product Picture
Figure 5. 300mg Product Picture
Figure 6. Global Moclobemide Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Moclobemide Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Moclobemide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Moclobemide Market Size (2018-2029) & (US$ Million)
Figure 13. Global Moclobemide Sales (2018-2029) & (Ton)
Figure 14. Global Moclobemide Average Price (US$/Kg) & (2018-2029)
Figure 15. Moclobemide Report Years Considered
Figure 16. Moclobemide Sales Share by Manufacturers in 2022
Figure 17. Global Moclobemide Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Moclobemide Players: Market Share by Revenue in 2022
Figure 19. Moclobemide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Moclobemide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Moclobemide Sales Market Share by Country (2018-2029)
Figure 22. North America Moclobemide Revenue Market Share by Country (2018-2029)
Figure 23. United States Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Moclobemide Sales Market Share by Country (2018-2029)
Figure 26. Europe Moclobemide Revenue Market Share by Country (2018-2029)
Figure 27. Germany Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Moclobemide Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Moclobemide Revenue Market Share by Region (2018-2029)
Figure 34. China Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Moclobemide Sales Market Share by Country (2018-2029)
Figure 44. Latin America Moclobemide Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Moclobemide Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Moclobemide Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Moclobemide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Moclobemide by Type (2018-2029)
Figure 54. Global Revenue Market Share of Moclobemide by Type (2018-2029)
Figure 55. Global Moclobemide Price (US$/Kg) by Type (2018-2029)
Figure 56. Global Sales Market Share of Moclobemide by Application (2018-2029)
Figure 57. Global Revenue Market Share of Moclobemide by Application (2018-2029)
Figure 58. Global Moclobemide Price (US$/Kg) by Application (2018-2029)
Figure 59. Moclobemide Value Chain
Figure 60. Moclobemide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed